Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105420285B reveals a scalable enzymatic method for producing optically active heptadecene compounds, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Discover the advanced Lewis acid-mediated reduction and enzymatic resolution process for high-purity cis-4-O-protected-2-cyclopentenol derivatives used in immunosuppressants.
Patent CN106520651A details enzymatic L-norvaline production. High purity, scalable process offers supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN102925528B reveals a novel nitrilase-catalyzed route for high-purity levo-praziquantel intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Enzymatic resolution patent CN112442523B enables high-purity chiral intermediate production with reduced costs and scalable supply chain reliability for global pharma.
Patent CN1220702A details a novel enzymatic process for producing high-purity optically active amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.
Patent CN104450853B reveals green recycling method. Reduces waste and ensures high-purity pharmaceutical intermediates for cost-effective manufacturing and supply chain reliability.
Patent CN1993472A details a lipase-catalyzed route for chiral 3-hydroxy acids, offering cost reduction in API manufacturing and superior supply chain reliability.
Patent CN101974603B reveals a novel NAD-independent enzymatic resolution method for high-purity D-alpha-hydroxybutyric acid, offering significant cost reduction and scalable supply chain solutions.
Novel lipase mutant enhances Pregabalin intermediate synthesis efficiency and purity. Cost-effective biocatalytic solution for pharmaceutical manufacturing supply chains.
Patent CN112481320B details a novel recombinant lactamase for producing optically pure (-)-γ-lactam. This breakthrough offers superior stability and stereoselectivity for antiviral drug synthesis.
Patent CN111057735B details a novel esterase route for high-purity chiral intermediates. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN110066835B details a novel lipase resolution process for agrochemical intermediates, offering superior enantioselectivity and cost-effective manufacturing solutions.
Patent CN109182298A reveals high-efficiency CALB mutants for chiral intermediate synthesis, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN112813131A reveals a high-efficiency carboxylesterase for producing Edoxaban intermediates with superior substrate tolerance and optical purity.
Patent CN110438194B details a novel lipase F11 for resolving DL-tropine methyl ester with >99% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN113481181B details a novel esterase mutant for resolving indoline derivatives, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN110592045B reveals high-purity enzymatic resolution for cardiovascular drug intermediates, offering scalable supply chain solutions.
Patent CN110055297B details a novel esterase for resolving (R,S)-5-caprolactone with >98% ee. Discover cost-effective biocatalytic routes for high-purity flavor intermediates.
Patent CN113201516B reveals a solvent-free enzymatic route for L-menthol with >95% ee. Discover cost-effective manufacturing solutions for high-purity terpene alcohols.